» Articles » PMID: 8143848

Peroxynitrite Releases Copper from Caeruloplasmin: Implications for Atherosclerosis

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1994 Mar 28
PMID 8143848
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxynitrite may be formed in the vasculature by the reaction of superoxide with nitric oxide. When the blue copper-containing protein, caeruloplasmin, is incubated with peroxynitrite, copper is released, and ferroxidase activity and the blue colouration are lost. When plasma from normal subjects is incubated with peroxynitrite, the oxidant reacts with numerous plasma constituents but is still able to release copper from caeruloplasmin. As the ferroxidase activity of caeruloplasmin is lost in plasma in the presence of peroxynitrite, a second ferroxidase activity associated with peroxidised lipids, and not inhibited by azide, is formed.

Citing Articles

Intracellular peroxynitrite perturbs redox balance, bioenergetics, and Fe-S cluster homeostasis in Mycobacterium tuberculosis.

Dewan A, Jain C, Das M, Tripathi A, Sharma A, Singh H Redox Biol. 2024; 75:103285.

PMID: 39128229 PMC: 11369450. DOI: 10.1016/j.redox.2024.103285.


Copper(II) generates ROS and RNS, impairs antioxidant system and damages membrane and DNA in human blood cells.

Husain N, Mahmood R Environ Sci Pollut Res Int. 2019; 26(20):20654-20668.

PMID: 31104239 DOI: 10.1007/s11356-019-05345-1.


Effect of 6-month caloric restriction on Cu bound to ceruloplasmin in adult overweight subjects.

Piacenza F, Malavolta M, Basso A, Costarelli L, Giacconi R, Ravussin E J Nutr Biochem. 2015; 26(8):876-82.

PMID: 26001545 PMC: 4469556. DOI: 10.1016/j.jnutbio.2015.03.012.


The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury.

van Golen R, Reiniers M, Vrisekoop N, Zuurbier C, Olthof P, van Rheenen J Antioxid Redox Signal. 2013; 21(7):1098-118.

PMID: 24313895 PMC: 4123469. DOI: 10.1089/ars.2013.5751.


Potential Benefits of Peroxynitrite.

Nossaman B, Kadowitz P Open Pharmacol J. 2009; 2:31-53.

PMID: 19305646 PMC: 2659344. DOI: 10.2174/1874143600802010031.